Date
Nov 19, 2024
Attendees
(bolded names indicate attendance)
Stakeholder group | SHIELD organization | Name of SHIELD member | organization designation |
Industry Entity | Labgnostic, Inc. | Steve Box | primary |
| NEW: Scott Vardy | alternate | |
Epic | Dan Rutz | primary | |
|
| alternate | |
Biomerieux | Xavier Gansel | primary | |
|
| alternate | |
Roche | Nick Decker | primary | |
Roche | Yue Jin | alternate | |
Healthcare Provider | Indiana University/Indiana University Health/Association for Molecular Pathology | Mehdi Nassiri, MD | primary |
University of Wisconsin-Madison | Andrea Pitkus, PhD, MLS(ASCP)CM, FAMIA | primary | |
UT Southwestern Medical Center | Hung Luu | primary | |
UNMC | Scott Campbell | primary | |
Tufts Medical Center | Nanguneri Nirmala | primary | |
Sonic Healthcare | Eric Crugnale | primary | |
Former Quest Diagnostics | Collom, Craig D | primary | |
Patient Advocate |
| Stacy Lange | individual |
Standards Organization | SNOMED International
| Jim Case | primary |
Monica Harry | alternate | ||
Regenstrief Institute
| Marjorie Rallins | primary | |
Eza Hafeza | alternate | ||
HL7
| Julia Skapik | primary | |
| alternate | ||
Professional Organization | Association of Public Health Laboratories
| Riki Merrick | primary |
NEW: Christina Gallegos | alternate | ||
Graphite Health
| Stan Huff - regrets | primary | |
| alternate | ||
CAP
| Raj Dash - regrets | primary | |
| alternate | ||
AMP
| Robyn Temple- regrets | primary | |
| alternate | ||
Governmental - non Voting | CMS | Michael Smalara | primary |
Open | alternate | ||
ONC | Sara Armson | primary | |
| alternate | ||
CDC | Hubert Vesper (/DDNID/NCEH/DLS) | primary | |
| alternate | ||
NLM | John Snyder | primary | |
| alternate | ||
FDA | Keith Campbell | primary | |
Victoria Derbyshire | alternate |
Agenda and Notes
Item | Notes |
---|---|
Quorum evaluation (two-thirds (2/3) of the Voting Representatives shall be necessary to constitute a quorum for the transaction of business) | Currently we have 19 named members, so 2/3 = 12 (excluding chair and government members).
|
Open Meeting | 12:09 PM ET - no quorum |
Collaborative Community Panel Presentation | Request to participate in Panel on December 17, 2024 3:50 - 4:20 PM ET - these would be the questions; Riki would attend, Andrea would join if she can.
|
Conferences | ASCLS got submitted - waiting for response ADLM got submitted - waiting for response |
Review Working Groups progress | Setting milestones for deliverables should be NEXT for WGs: they will be captured here: SHIELD WG Deliverables and Milestone Grid
|
Lab LOINC Committee question | Question: Should LOINC support IFCC methods (as part of harmonization of tests) or should this be covered by the yet to created harmonization indicator? only 2 LOINCs with IFCC as method: Hemoglobin A1C, https://loinc.org/91671-8 Could have a result with IFCC method and without. Over 100 tests that are aligend with IFCC method - should more LOINCs be created? Compinatorial explosion is not good, but we don’t currenlty have HL7 place for the harmonization indicator, but if we can create specific method codes that could cover that and we have had OBX-17 for a long time (some LIS/EHR-s may not support that field yet) SNOMED CT collaboration on LOINC parts modeling around methods Sometimes method is in the lab testname, but even then the LOINC chosen may be a methodless code (on the lab side, but also on the EHR-s side) Method axis in LOINC supports multiple - example would be toxicology testing - SAMSHA drug testing requires different methods based on screening / confirmatory test type / cut-off based / detection limit Sequoia IG Update - still working on addressing comments - suring a call a newer clinician participating also requested this harmonization indicator to help idetify results that can be merged |
Administrative things | Review SC Composition, terms and requirements for re-voting:
|
Roadmap section updates in response to ONC comments on the SHIELD roadmap |
Updated language draft: Roadmap update: ONC Feedback maybe add one more sentence or add a reference to the key consideration number for the IVD Datahub (Consideration 4) into these sentences. (change approved in principle.) Discussion:
Update from Standards and Vocab WG about re-write of this section - from their March 18th call (notes here, recording here)
Discussion:
Identify components that could improve the ecosystem infrastructure, and then highlight the places where these components can be advanced / sustained or made easier to implement. Would SHIELD be willing to consider to provide an example implementation - create the structures and bound terminologies to showcase how each element would be properly represented be working. For each of the Consideration sections we could certainly add a section on feasibility / requirements (e.g. continued funding for LIDR, better describing the intended use of ANY data element added, overall goal of LIDR, clearly delineate what is commonly used and is minimum, provide best practice and alternatives (non-preferred) - example would be metadata around the value sets in VSAC (curation / usage etc) to be able to ascertain quality) and highlight that other mechanisms are needed to achieve for adoption. |
ONC Annual Meeting December 4-5, 2024 | https://www.astpannualmeeting.com/Agenda This is in-person only, registration is open now - last year it filed up no plans so far to have slides / recording available December 5th 2:15 – 3:15 pm is Enhancing Laboratory Interoperability: Insights and a Path Forward - Sara can give update on January 14th call to SHIELD members Also the report to congress wil be public one sent off |
Antimicrobial result reporting | Placeholder to get back to later Related work at HL7 Europe: |
Next calls | All SHIELD Calls
General Updates: 2024 - WG Chairs please make sure we have material for updates (at least notes we can link to) Special Topic:
Steering Committee:
|
Adjourned | 11:54 AM ET |
From Chat:
Jim Case 12:10 PM
Yes, doodle poll is good for new timeAndrea Pitkus 12:18 PM
Would it be FHIR based or could HL7 support a non FHIR based solution?
Nick Decker (Roche) 12:20 PM
TruvetaNick Decker (Roche) to Everyone 12:20 PM
https://www.truveta.com/truveta-data/regulatory-grade/Andrea Pitkus 12:21 PM
They advertise supporting newborn screening panels ;)
Julia Skapik 12:22 PM
I'm still willing to help with standards and vocabulary but I can think of a couple of other folks who might be willing to helpEric Crugnale 12:23 PM
SHIELD Membership Survey (https://airtable.com/appOlWUgNBTLteZAC/shrRB3rxwuF4ZAOLS)Nick Decker (Roche) 12:34 PM
I need to run to this call with Truveta - thanks allAndrea Pitkus 12:51 PM
IS this the detection limit LOINC, Riki? https://loinc.org/101128-7
Action items
Quick decisions not requiring context or tracking
For quick, smaller decisions that do not require extra context or formal tracking, use the “Add a decision…” function here.
Decisions requiring context or tracking
For decisions that require more context (e.g., documentation of discussion, options considered) and/or tracking, use the decision template to capture more information.